You are here

  • Home
  • Archive
  • Volume 10, Issue 11
  • Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: a joint analysis of OnCovid and ESMO-CoCARE registries

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: a joint analysis of OnCovid and ESMO-CoCARE registries

 

Online download statistics by month:

Online download statistics by month: November 2022 to July 2025

AbstractFullPdf
Nov 202277778
Dec 2022606613406
Jan 2023292292111
Feb 202316016156
Mar 2023767939
Apr 2023787948
May 2023505031
Jun 2023292911
Jul 2023474721
Aug 2023434324
Sep 2023494925
Oct 2023444430
Nov 2023313121
Dec 2023616238
Jan 2024464740
Feb 2024575737
Mar 20244546112
Apr 2024515180
May 2024353624
Jun 2024393924
Jul 2024676837
Aug 2024343322
Sep 20244343110
Oct 2024505024
Nov 2024373825
Dec 2024686930
Jan 2025676745
Feb 202519519529
Mar 2025535374
Apr 2025565673
May 2025383835
Jun 2025454529
Jul 2025110
Total267026881719